evans blue has been researched along with Cancer of Nasopharynx in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Olivo, M; Soo, KC; Yee, KK | 1 |
Hilgers, F; Hilgers, J | 1 |
2 other study(ies) available for evans blue and Cancer of Nasopharynx
Article | Year |
---|---|
Anti-angiogenic effects of Hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Anthracenes; Celecoxib; Cyclooxygenase 2; Drug Therapy, Combination; Evans Blue; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Male; Mice; Mice, Inbred BALB C; Middle Aged; Nasopharyngeal Neoplasms; Necrosis; Neovascularization, Pathologic; Perylene; Photochemotherapy; Pyrazoles; RNA, Messenger; Sulfonamides; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
An immunofluorescence technique with counterstain on fixed cells for the detection of antibodies to human herpesviruses; antibody patterns in patients with Hodgkin's disease and nasopharyngeal carcinoma.
Topics: Antibodies, Viral; Carcinoma; Complement Fixation Tests; Cytomegalovirus; Evans Blue; Female; Fluorescent Antibody Technique; Herpesviridae; Herpesvirus 3, Human; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunodiffusion; Male; Nasopharyngeal Neoplasms; Simplexvirus; Staining and Labeling | 1976 |